Logo
  • Real Estate
  • Personal Finance
  • Health & Wellness
  • Financials
  • DMCA
  • About Us
  • Terms of Service
  • Privacy Policy
©2021 Market Realist. All rights reserved.

Orexigen Therapeutics Inc

Most Recent

  • uploads/2016/03/Pipeline-for-obesity-drugs1.png
    .
    Company & Industry Overviews

    How Much Potential Does Saxenda Hold for Novo?

    Saxenda, a glucagon-like peptide-1 (or GLP-1) analog therapy, holds 31% market share for branded anti-obesity drugs.

    By Jillian Dabney5 years ago
Do Not Sell My Personal Information